IL99864A - Compositions for suppressing transplant rejection in mammals which contain tissue donor derived MHC antigens - Google Patents

Compositions for suppressing transplant rejection in mammals which contain tissue donor derived MHC antigens

Info

Publication number
IL99864A
IL99864A IL9986491A IL9986491A IL99864A IL 99864 A IL99864 A IL 99864A IL 9986491 A IL9986491 A IL 9986491A IL 9986491 A IL9986491 A IL 9986491A IL 99864 A IL99864 A IL 99864A
Authority
IL
Israel
Prior art keywords
mammals
compositions
transplant rejection
mhc antigens
donor derived
Prior art date
Application number
IL9986491A
Other languages
English (en)
Other versions
IL99864A0 (en
Original Assignee
Autoimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autoimmune Inc filed Critical Autoimmune Inc
Publication of IL99864A0 publication Critical patent/IL99864A0/xx
Publication of IL99864A publication Critical patent/IL99864A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL9986491A 1990-10-31 1991-10-27 Compositions for suppressing transplant rejection in mammals which contain tissue donor derived MHC antigens IL99864A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60782690A 1990-10-31 1990-10-31

Publications (2)

Publication Number Publication Date
IL99864A0 IL99864A0 (en) 1992-08-18
IL99864A true IL99864A (en) 2000-11-21

Family

ID=24433875

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9986491A IL99864A (en) 1990-10-31 1991-10-27 Compositions for suppressing transplant rejection in mammals which contain tissue donor derived MHC antigens

Country Status (11)

Country Link
US (2) US5681556A (fr)
EP (1) EP0555413A4 (fr)
JP (1) JP2547162B2 (fr)
KR (1) KR0161235B1 (fr)
AU (1) AU662500B2 (fr)
BR (1) BR9107055A (fr)
CA (1) CA2093513C (fr)
HU (1) HUT63957A (fr)
IL (1) IL99864A (fr)
NO (1) NO931536L (fr)
WO (1) WO1992007581A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571500A (en) * 1987-06-24 1996-11-05 Autoimmune, Inc. Treatment of autoimmune diseases through administration by inhalation of autoantigens
US5645820A (en) * 1987-06-24 1997-07-08 Autoimmune, Inc. Treatment of autoimmune diseases by aerosol administration of autoantigens
US5571499A (en) * 1987-06-24 1996-11-05 Autoimmune, Inc. Treatment of autoimmune diseases by aerosol administration of autoantigens
US5641474A (en) * 1987-06-24 1997-06-24 Autoimmune, Inc. Prevention of autoimmune diseases by aerosol administration of autoantigens
IL99699A (en) 1990-10-10 2002-04-21 Autoimmune Inc Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
MX9203138A (es) * 1991-03-12 1992-09-01 Biogen Inc Dominio de enlace cd2-de antigeno 3 (lfa-3) asociado con funcion linfositos.
SG47766A1 (en) * 1991-03-12 1998-04-17 Biogen Inc CD2-binding domain of lymphocyte function associated antigen 3
US6764681B2 (en) 1991-10-07 2004-07-20 Biogen, Inc. Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
GB9319429D0 (en) 1993-09-21 1993-11-03 London Health Ass Methods and products for controlling immune responses in mammals
JPH09508277A (ja) * 1994-01-27 1997-08-26 ブレサゲン リミテッド ヒト異種移植における超急性拒絶の管理のための物質及び方法
US5849991A (en) 1994-01-27 1998-12-15 Bresatch Limited Mice homozygous for an inactivated α 1,3-galactosyl transferase gene
JPH08239324A (ja) * 1995-03-03 1996-09-17 Fusanori Hamashima 免疫抑制剤
US20020155117A1 (en) * 1996-04-04 2002-10-24 Nicole Suciu-Foca Method for detecting organ allograft rejection and uses thereof
IL126714A (en) * 1997-02-28 2010-12-30 Enzo Therapeutics Inc Use of cells, organs or components thereof for the preparation of a pharmaceutical composition for establishing selective immune downregulation
US7097845B2 (en) 1997-04-23 2006-08-29 Jacob Sten Petersen Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
US6685936B2 (en) * 1999-10-12 2004-02-03 Osiris Therapeutics, Inc. Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation
US20020012667A1 (en) * 2000-05-16 2002-01-31 Mcmichael John Method for preventing allograft rejection
US7261896B2 (en) 2000-05-24 2007-08-28 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health Methods for preventing strokes by inducing tolerance to e-selectin
US20030170258A1 (en) * 2001-05-09 2003-09-11 Enzo Therapeutics, Inc. Novel processes implementing selective immune down regulation (SIDR)
WO2003009740A2 (fr) 2001-07-24 2003-02-06 Biogen Idec Ma Inc. Methodes de traitement ou de prevention de troubles sclereux par l'usage d'agents se liant a cd2
JP2005514344A (ja) * 2001-10-25 2005-05-19 アセロジエニクス・インコーポレイテツド 移植拒絶治療のための化合物と方法
CA2565259A1 (fr) 2004-05-07 2005-12-08 Astellas Us Llc Polypeptide lfa-3 soluble destine a traiter de troubles viraux

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5899419A (ja) * 1981-12-07 1983-06-13 Green Cross Corp:The 免疫抑制剤
JPS59116224A (ja) * 1982-10-01 1984-07-05 デイミトリ・アダモポ−ロス 免疫反応を抑制する組成物およびその製法
US4635627A (en) * 1984-09-13 1987-01-13 Riker Laboratories, Inc. Apparatus and method
US5130297A (en) * 1988-06-23 1992-07-14 Anergen, Inc. Conjugates useful in ameliorating autoimmunity MHC-II-peptide
US5011037A (en) * 1989-11-30 1991-04-30 Adolph Coors Company Container end member
RU2054180C1 (ru) * 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций

Also Published As

Publication number Publication date
NO931536D0 (no) 1993-04-27
AU8942691A (en) 1992-05-26
AU662500B2 (en) 1995-09-07
KR930701969A (ko) 1993-09-08
JPH05508663A (ja) 1993-12-02
WO1992007581A1 (fr) 1992-05-14
IL99864A0 (en) 1992-08-18
CA2093513C (fr) 1999-03-23
EP0555413A1 (fr) 1993-08-18
NO931536L (no) 1993-04-27
HUT63957A (en) 1993-11-29
US5788968A (en) 1998-08-04
EP0555413A4 (en) 1994-12-07
US5681556A (en) 1997-10-28
CA2093513A1 (fr) 1992-05-01
JP2547162B2 (ja) 1996-10-23
KR0161235B1 (ko) 1998-12-01
BR9107055A (pt) 1993-09-21
HU9301252D0 (en) 1993-07-28

Similar Documents

Publication Publication Date Title
IL99864A (en) Compositions for suppressing transplant rejection in mammals which contain tissue donor derived MHC antigens
GB8431896D0 (en) Silicone release compositions
AU6096496A (en) Allogeneic and xenogeneic transplantation
EP0466552A3 (en) Biomedical adhesive compositions
ZA913751B (en) Controlled release composition
BR9306345A (pt) Métodos para suprimir a habilidade de células-t de um mamífero de proliferar e para suprimir resposta imune composições para uso na supressão da capacidade de células-t de proliferarem e na supressão de resposta imune
EP0451946A3 (en) Storage stable one-part organosiloxane compositions
EP0469927A3 (en) High-strength silicone rubber compositions
EP0322848A3 (en) Thermally stable organosiloxane compositions and method for preparing same
EP0459675A3 (en) Adhesive organopolysiloxane composition
EP0453286A3 (en) Superabsorbent foam composition
EP0577335A3 (en) Storage stable one-part organosiloxane compositions and methods for preparing same
GB9001694D0 (en) Immunogenic compositions
EP0451903A3 (en) Composition for the regulation of hair growth
CA2120731A1 (fr) Methodes d'amelioration de la tolerance d'allogreffes ou de xenogreffes par l'administration d'une proteine se liant a lfa-3 ou a cd2
GB2255909B (en) Vaccine compositions for fish
GB9018839D0 (en) Slow release compositions
GB8431897D0 (en) Silicone release compositions
EP0516855A4 (en) Polyisocyanate composition
AU176P (en) HAPPY DAYS Rosa hybrid
IE902010L (en) Inhibiting transplant rejection
GB9021004D0 (en) Acellular vaccines
ZA916063B (en) Composition for eye drops
GB9000534D0 (en) Mould release compositions
GB2248438B (en) Device for the automatic insertion of slides in slide mounts

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees